Literatur
Baker DE (2001) Pegylated interferons. Rev Gastroenterol Disord 1: 87–99
English JC 3rd, Patel PJ, Greer KE (2001) Sarcoidosis. J Am Acad Dermatol 44: 725–743; quiz 44–46
Guilabert A, Bosch X, Julia M et al. (2005) Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin. Br J Dermatol 152: 377–379
Harris JM, Martin NE, Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40: 539–551
Manjon-Haces JA, Vazquez-Lopez F, Gomez-Diez S et al.(2001) Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 81: 223
Meller S, Erhardt A, Auci A et al. (2003) Drug-induced exanthema caused by pegylated interferon-alpha 2b. Hautarzt 54: 992–993
Raanani P, Ben-Bassat I (2002) Immune-mediated complications during interferontherapy in hematological patients. Acta Haematol 107: 133–144
Rogers CJ, Romagosa R, Vincek V (2004) Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. J Am Acad Dermatol 50: 649–650
Rubinowitz AN, Naidich DP, Alinsonorin C (2003) Interferon-induced sarcoidosis. J Comput Assist Tomogr 27: 279–283
Taylor C, Burns DA, Wiselka MJ (2000) Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J 76: 365–367
Walter MR, Bordens R, Nagabhushan TL et al. (1998) Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. Cancer Biother Radiopharm 13: 143–154
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meller, S., Reifenberger, J., Ruzicka, T. et al. Induktion einer Sarkoidose unter Therapie mit pegyliertem Interferon-α2a. Hautarzt 57, 317–318 (2006). https://doi.org/10.1007/s00105-006-1108-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-006-1108-9